A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAPLACIZUMAB WITHOUT FIRST-LINE THERAPEUTIC PLASMA EXCHANGE IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPUR... by Sriya GUNAWARDENA, MD, Angela HU, MD, Laurel A. MENAPACE, MD, Hikaru OKADA, MD, PhD, Beverly ACCOMANDO, MS, Julie LIN, MD

Get full text